SCHEMBL18790961

SCHEMBL18790961

CCOC(=O)CN1CCN(c2cncc(-c3ccc(F)cc3)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 6/20 0.51
▸ DRD2 P14416 5/20 0.51
▸ DRD3 P35462 5/20 0.51
▸ ENPP2 Q13822 1/20 0.46
▸ CYP11B2 P19099 1/20 0.46
▸ CHRNB4 P30926 1/20 0.45
▸ CHRNA3 P32297 1/20 0.45
▸ CYP3A4 P08684 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18790963 0.84 DRD4 (0.57) DRD4DRD2DRD3CYP11B2CHRNB4
SCHEMBL20271748 0.82 ALDH1A1 (0.56) DRD4CYP3A4KDM4EGAAPOLB
SCHEMBL20271781 0.75 SLC27A1 (0.54) DRD4DRD2DRD3POLBSMN1; SMN2
SCHEMBL18502911 0.74 CYP11B2 (0.64) CYP11B2
SCHEMBL18790711 0.73 GPR119 (0.48) DRD4DRD2DRD3CHRNB4CHRNA3
SCHEMBL15556515 0.72 MAPK1 (0.51) DRD4DRD2
SCHEMBL14860445 0.72 ALDH1A1 (0.60) DRD2KDM4ETSHRHTTSMN1; SMN2
SCHEMBL10763058 0.71 SMN1; SMN2 (0.52) TSHRPOLBHTTSMN1; SMN2ALDH1A1
SCHEMBL7356492 0.70 F2 (0.52) TSHRSMN1; SMN2ALDH1A1
SCHEMBL6005398 0.70 HTR1A (0.59) DRD4DRD2DRD3CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2020-07-21 — — US disclosed
WO-2017069226-A1 NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND 田辺三菱製薬株式会社 2017-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound REN, NR3C2, NR5A1 DRD4 4200/4885DRD2 4260/4885DRD3 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback